Watson Acquisition Of Andrx Includes Drug Delivery Technology, ANDA Hold
Executive Summary
Watson's acquisition of Andrx will provide the company with 15 drug delivery technologies, including delayed and sustained-release formulations
You may also be interested in...
Watson Will Pursue “Balanced” Generic Portfolio, CEO Bisaro Says
Watson Pharmaceuticals will aim for a "balanced" generic drug portfolio by moving beyond "commodity" products to include more of those that are especially difficult to formulate or manufacture, new President and CEO Paul Bisaro said during the firm's third quarter earnings call Nov. 6
Watson Will Pursue “Balanced” Generic Portfolio, CEO Bisaro Says
Watson Pharmaceuticals will aim for a "balanced" generic drug portfolio by moving beyond "commodity" products to include more of those that are especially difficult to formulate or manufacture, new President and CEO Paul Bisaro said during the firm's third quarter earnings call Nov. 6
Generic Firms Need Vertical Integration To Thrive In Current Price Environment
Generic companies will need to have vertically integrated operations in order to succeed in an increasingly flat pricing environment, ABN AMRO Director-Healthcare Tommy Erdei said